Education
About Us
Working with TipRanks
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
TNXP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.76 - $130.35
Previous CloseN/A
Volume36.66M
Average Volume (3M)1.99M
Market Cap
$298.13M
Enterprise Value$138.80M
Total Cash (Recent Filing)$125.33M
Total Debt (Recent Filing)$492.00K
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Nov 10, 2025EPS Estimate
-3.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.86
Shares Outstanding8,765,896
10 Day Avg. Volume2,862,282
30 Day Avg. Volume1,991,963
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.47
Enterprise Value/Revenue14.12
Enterprise Value/Gross Profit48.23
Enterprise Value/Ebitda-1.71
Forecast
1Y Price Target
$67.50Price Target Upside109.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Tonix Pharma News
TNXP FAQ
What was Tonix Pharma’s price range in the past 12 months?
Tonix Pharma lowest stock price was $6.76 and its highest was $130.35 in the past 12 months.
What is Tonix Pharma’s market cap?
Tonix Pharma’s market cap is $298.13M.
When is Tonix Pharma’s upcoming earnings report date?
Tonix Pharma’s upcoming earnings report date is Nov 10, 2025 which is in 73 days.
How were Tonix Pharma’s earnings last quarter?
Tonix Pharma released its earnings results on Aug 11, 2025. The company reported -$3.86 earnings per share for the quarter, missing the consensus estimate of -$2.77 by -$1.09.
Is Tonix Pharma overvalued?
According to Wall Street analysts Tonix Pharma’s price is currently Undervalued.
Does Tonix Pharma pay dividends?
Tonix Pharma does not currently pay dividends.
What is Tonix Pharma’s EPS estimate?
Tonix Pharma’s EPS estimate is -3.31.
How many shares outstanding does Tonix Pharma have?
Tonix Pharma has 8,765,896 shares outstanding.
What happened to Tonix Pharma’s price movement after its last earnings report?
Tonix Pharma reported an EPS of -$3.86 in its last earnings report, missing expectations of -$2.77. Following the earnings report the stock price went up 32.889%.
Which hedge fund is a major shareholder of Tonix Pharma?
Currently, no hedge funds are holding shares in TNXP
Tonix Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$67.50 (109.76% Upside)
$67.50 (109.76% Upside)
Blogger Sentiment
Bullish
TNXP Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $24.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.06%
12-Months-Change
Fundamentals
Return on Equity
-77.51%
Trailing 12-Months
Asset Growth
166.49%
Trailing 12-Months
Company Description
Tonix Pharma
Tonix Pharmaceuticals Holding Corp. (TNXP) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, pain management, and other related conditions. The company is primarily engaged in the research, development, and commercialization of its proprietary medicines, with a strong emphasis on addressing unmet medical needs in various therapeutic areas. Tonix's core products include novel formulations and repurposed drugs aimed at improving treatment outcomes for patients suffering from conditions such as post-traumatic stress disorder (PTSD), fibromyalgia, and migraine.
TNXP Stock 12 Month Forecast
Average Price Target
$67.50
▲(109.76% Upside)
Technical Analysis
Coherus Biosciences
―
Nektar Therapeutics
―
Cellectis SA
―
Editas Medicine
―
Instil Bio
―
Ownership Overview
0.05% Insiders
1.63% Mutual Funds
0.07% Other Institutional Investors
92.31% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---